STAB1 and lymphoma: Additionally, preclinical studies using Stab1 KO mice confirmed that the absence of STAB1+ TAMs resulted in reduced tumor burden of several cancers, including melanoma, lung adenocarcinoma, medullary mammary adenocarcinoma, and lymphoma [42,50].